Vaccines

Latest content and products

Toni Ertl, Senior Scientist at The Native Antigen Company

Recombinant protein advancements revolutionize assay development

Toni Ertl shares how The Native Antigen Company’s new human health recombinant proteins are advancing assay development in diagnostics and vaccine research

27 Oct 2025

Industry NewsDrug Discovery & Development

FUJIFILM Irvine Scientific is now officially FUJIFILM Biosciences

8 Jan 2026

Industry NewsDrug Discovery & Development

Thermo Fisher Scientific deepens investment in Asia’s biopharma ecosystem

30 Dec 2025

Product NewsDrug Discovery & Development

Bio-Rad extends range of Foresight Pro prepacked chromatography columns for biotherapeutic production

8 Jan 2025

Webinars

Self-Amplifying RNA in Vaccines and Beyond

Speakers: Mark Shulewitz, PhD, GenScript USA Inc, Matilde Marques, SelectScience

18 Dec 2024

Watch on-demand

Applications and Challenges of Neoantigen Peptides in Personalized Cancer Vaccines

Speakers: Shan She, PhD, GenScript Biotech Corporation, Matilde Marques, SelectScience

20 Nov 2024

Watch on-demand

Editorial Articles

Editorial Article

Recombinant protein advancements revolutionize assay development

27 Oct 2025

Latest Videos

Product News

Advancing lab access to lyophilized bead technology

25 Feb 2025

John Holtzclaw, scientific advisor, Eurofins Viracor Biopharma

SelectScience Interviews

5 potential pitfalls to avoid for successful vaccine trials

6 Nov 2024

Resources

White Papers

Your freeze-drying laboratory guide from BUCHI

18 Mar 2025

Application Note

5 potential pitfalls to avoid for successful vaccine trials: Presentation handout

5 Nov 2024

White Papers

Virus-like particles as a practical alternative to cultured rubella virus

5 Nov 2024

Application Note

Calibration of NAB-Sure Neutralizing Antibody Titer using WHO International Standard

28 Oct 2024

News

Industry News

FUJIFILM Irvine Scientific is now officially FUJIFILM Biosciences

8 Jan 2026

Industry News

Thermo Fisher Scientific deepens investment in Asia’s biopharma ecosystem

30 Dec 2025

Professor Ahmed Ahmed, Director of the Ovarian Cancer Cell Laboratory, MRC Weatherall Institute of Molecular Medicine at the University of Oxford and lead for the OvarianVax project

Industry News

Oxford researchers secure funding for world's first ovarian cancer prevention vaccine

29 Oct 2024